Cell survival pathways targeted in rare lung disease affecting women

Novel drug targets are identified in lymphangioleiomyomatosis (LAM), a rare disease in women. These targets focus on uterine transcription factors necessary for LAM cell survival.

Detalles Bibliográficos
Autores principales: Yang, Bennett, Moss, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2023
Materias:
Focus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171799/
https://www.ncbi.nlm.nih.gov/pubmed/37163598
http://dx.doi.org/10.1126/sciadv.adi1215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171799/
https://www.ncbi.nlm.nih.gov/pubmed/37163598
http://dx.doi.org/10.1126/sciadv.adi1215

Ejemplares similares